Literature DB >> 7979045

Modulation of collagen synthesis by transforming growth factor-beta in keloid and hypertrophic scar fibroblasts.

S Younai1, L S Nichter, T Wellisz, J Reinisch, M E Nimni, T L Tuan.   

Abstract

Keloid and hypertrophic scars are fibrous growths characterized by overabundant collagen deposition. We examined the effect of transforming growth factor-beta (TGF-beta), a known stimulant for the production of connective tissue matrices, on the rate of collagen synthesis in keloid fibroblasts (KFs), hypertrophic scar fibroblasts (HSFs), and normal skin fibroblasts (NSFs). Fibroblasts were cultured in three-dimensional fibrin-gel matrices in the presence or absence of TGF-beta (5 ng/ml) or anti-TGF-beta neutralizing antibody (50 micrograms/ml). Secreted collagen levels, labeled with 3H-proline, were measured after 48 hours. KFs produced up to 12 times more collagen than NSFs, and up to 4 times more than HSFs. Although KFs increased their rate of collagen production by up to 2.7 times in response to TGF-beta, HSFs and NSFs did not (p = 0.065). Anti-TGF-beta antibody reduced the rate of collagen synthesis of KFs by 40% (p = 0.003), although it did not suppress collagen production in HSFs (p = 0.06) and NSFs (p = 0.75). We conclude that although KFs and HSFs are similar in that they both overproduce collagen, they are different in that only KFs display a marked sensitivity to TGF-beta, which is abundant during the proliferative phase of wound healing.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7979045     DOI: 10.1097/00000637-199408000-00005

Source DB:  PubMed          Journal:  Ann Plast Surg        ISSN: 0148-7043            Impact factor:   1.539


  33 in total

Review 1.  Aging and wound healing.

Authors:  Ankush Gosain; Luisa A DiPietro
Journal:  World J Surg       Date:  2004-02-17       Impact factor: 3.352

Review 2.  A primary care perspective on keloids.

Authors:  Steven Davidson; Nasir Aziz; Rashid M Rashid; Amor Khachemoune
Journal:  Medscape J Med       Date:  2009-01-20

Review 3.  [Therapy of keloids].

Authors:  S Karrer
Journal:  Hautarzt       Date:  2007-11       Impact factor: 0.751

4.  Transforming growth factor-β3 regulates assembly of a non-fibrotic matrix in a 3D corneal model.

Authors:  D Karamichos; A E K Hutcheon; J D Zieske
Journal:  J Tissue Eng Regen Med       Date:  2011-05-23       Impact factor: 3.963

Review 5.  Update on Postsurgical Scar Management.

Authors:  Sarah Jane Commander; Edward Chamata; Joshua Cox; Ryan M Dickey; Edward I Lee
Journal:  Semin Plast Surg       Date:  2016-08       Impact factor: 2.314

6.  Increased plasminogen activator inhibitor-1 in keloid fibroblasts may account for their elevated collagen accumulation in fibrin gel cultures.

Authors:  Tai-Lan Tuan; Huayang Wu; Eunice Y Huang; Sheree S N Chong; Walter Laug; Diana Messadi; Paul Kelly; Anh Le
Journal:  Am J Pathol       Date:  2003-05       Impact factor: 4.307

Review 7.  Update on Keloid Management: Clinical and Basic Science Advances.

Authors:  Martha H Viera; Alejandra C Vivas; Brian Berman
Journal:  Adv Wound Care (New Rochelle)       Date:  2012-10       Impact factor: 4.730

8.  Effect of mitomycin on normal dermal fibroblast and HaCat cell: an in vitro study.

Authors:  Yao-wen Wang; Ji-hao Ren; Kun Xia; Shu-hui Wang; Tuan-fang Yin; Ding-hua Xie; Li-hua Li
Journal:  J Zhejiang Univ Sci B       Date:  2012-12       Impact factor: 3.066

9.  Role of Hyaluronic Acid Treatment in the Prevention of Keloid Scarring.

Authors:  Andrea Hoffmann; Jessica Lynn Hoing; Mackenzie Newman; Richard Simman
Journal:  J Am Coll Clin Wound Spec       Date:  2013-07-01

10.  Dynamic biological changes in fibroblasts during hypertrophic scar formation and regression.

Authors:  Qing Chun; Wang ZhiYong; Song Fei; Wang XiQiao
Journal:  Int Wound J       Date:  2014-05-07       Impact factor: 3.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.